4-2825178-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001122681.2(SH3BP2):āc.410A>Gā(p.Asp137Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 1,581,368 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D137E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001122681.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH3BP2 | NM_001122681.2 | c.410A>G | p.Asp137Gly | missense_variant | 5/13 | ENST00000503393.8 | |
SH3BP2 | NM_001145856.2 | c.581A>G | p.Asp194Gly | missense_variant | 5/13 | ||
SH3BP2 | NM_001145855.2 | c.494A>G | p.Asp165Gly | missense_variant | 5/13 | ||
SH3BP2 | NM_003023.4 | c.410A>G | p.Asp137Gly | missense_variant | 5/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH3BP2 | ENST00000503393.8 | c.410A>G | p.Asp137Gly | missense_variant | 5/13 | 1 | NM_001122681.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151868Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000256 AC: 5AN: 195178Hom.: 1 AF XY: 0.0000381 AC XY: 4AN XY: 105056
GnomAD4 exome AF: 0.0000112 AC: 16AN: 1429500Hom.: 1 Cov.: 32 AF XY: 0.0000155 AC XY: 11AN XY: 708240
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151868Hom.: 0 Cov.: 34 AF XY: 0.0000405 AC XY: 3AN XY: 74156
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.410A>G (p.D137G) alteration is located in exon 5 (coding exon 4) of the SH3BP2 gene. This alteration results from a A to G substitution at nucleotide position 410, causing the aspartic acid (D) at amino acid position 137 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Fibrous dysplasia of jaw Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 18, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 137 of the SH3BP2 protein (p.Asp137Gly). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SH3BP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 525199). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SH3BP2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at